Evolution of Rituximab as “Standard” Therapy in Patients (pts) with Newly Diagnosed Follicular (FL), Mantle Cell (MCL), and Diffuse Large B Cell (DLCL) Non-Hodgkin's Lymphoma (NHL)... von Friedberg, Jonathan W., Kho, Michelle E., Lepisto, Eva M., Rodriguez, M. Alma, TerVeer, Anna, LaCasce, Ann S., Nademanee, Auyporn P., Millenson, Michael, Czuczman, Myron, Niland, Joyce, Zelenetz, Andrew D., Weeks, Jane C.

Volltext